This file contains COVID-19 death counts, death rates, and percent of total deaths by jurisdiction of residence. The data is grouped by different time periods including 3-month period, weekly, and total (cumulative since January 1, 2020). United States death counts and rates include the 50 states, plus the District of Columbia and New York City. New York state estimates exclude New York City. Puerto Rico is included in HHS Region 2 estimates.

Deaths with confirmed or presumed COVID-19, coded to ICD–10 code U07.1. Number of deaths reported in this file are the total number of COVID-19 deaths received and coded as of the date of analysis and may not represent all deaths that occurred in that period. Counts of deaths occurring before or after the reporting period are not included in the file.

Data during recent periods are incomplete because of the lag in time between when the death occurred and when the death certificate is completed, submitted to NCHS and processed for reporting purposes. This delay can range from 1 week to 8 weeks or more, depending on the jurisdiction and cause of death.

Death counts should not be compared across states. Data timeliness varies by state. Some states report deaths on a daily basis, while other states report deaths weekly or monthly.

The ten (10) United States Department of Health and Human Services (HHS) regions include the following jurisdictions. Region 1: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont; Region 2: New Jersey, New York, New York City, Puerto Rico; Region 3: Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, West Virginia; Region 4: Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee; Region 5: Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin; Region 6: Arkansas, Louisiana, New Mexico, Oklahoma, Texas; Region 7: Iowa, Kansas, Missouri, Nebraska; Region 8: Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming; Region 9: Arizona, California, Hawaii, Nevada; Region 10: Alaska, Idaho, Oregon, Washington.

Rates were calculated using the population estimates for 2021, which are estimated as of July 1, 2021 based on the Blended Base produced by the US Census Bureau in lieu of the April 1, 2020 decennial population count. The Blended Base consists of the blend of Vintage 2020 postcensal population estimates, 2020 Demographic Analysis Estimates, and 2020 Census PL 94-171 Redistricting File (see https://www2.census.gov/programs-surveys/popest/technical-documentation/methodology/2020-2021/methods-statement-v2021.pdf).

Rates are based on deaths occurring in the specified week/month and are age-adjusted to the 2000 standard population using the direct method (see https://www.cdc.gov/nchs/data/nvsr/nvsr70/nvsr70-08-508.pdf). These rates differ from annual age-adjusted rates, typically presented in NCHS publications based on a full year of data and annualized weekly/monthly age-adjusted rates which have been adjusted to allow comparison with annual rates. Annualization rates presents deaths per year per 100,000 population that would be expected in a year if the observed period specific (weekly/monthly) rate prevailed for a full year.

Sub-national death counts between 1-9 are suppressed in accordance with NCHS data confidentiality standards. Rates based on death counts less than 20 are suppressed in accordance with NCHS standards of reliability as specified in NCHS Data Presentation Standards for Proportions (available from: https://www.cdc.gov/nchs/data/series/sr_02/sr02_175.pdf.).

An analysis published in May 2022 found that of the total 641,305 COVID-19 deaths reported in the United States between January 1, 2021 and April 30, 2022, around 318,981 could have been prevented if 100 percent of the population was vaccinated. During this period the state of West Virginia reported about 5,483 deaths related to COVID-19. It is estimated that if 100 percent of the population of West Virginia had been vaccinated then 3,350 of these deaths, or 61 percent, could have been prevented. As of May 2022, around 66 percent of the U.S. population had been fully vaccinated against COVID-19. This table shows the number of COVID-19 deaths in the United States between January 2021 and April 2022 that could have been prevented if 100 percent of the population had been vaccinated, by state.

Mandated reporting of Weekly Aggregate Case and Death Count data among dialysis patients and dialysis facility staff (healthcare personnel or HCP) in the United States was discontinued May 11, 2023, with the expiration of the COVID-19 public health emergency declaration. This dataset will contain weekly aggregate data from January 1, 2021, through May 10, 2023, and will remain publicly available. This archived public use dataset contains reported COVID-19 case and death data per week for all states and territories, along with weekly totals for the entire United States, throughout the given timeframe.

Between January 1, 2021 and April 30, 2022 the death rate due to COVID-19 in the United States was about 2,487 per one million population. An analysis published in May 2022 found that if 100 percent of the population in the United States had been vaccinated at this time then the death rate over this period would have been around 1,237 per one million population. It was estimated that a 100 percent vaccination rate could have prevented 318,981 of 641,305 total deaths reported over this period. As of May 2022, around 66 percent of the U.S. population had been fully vaccinated against COVID-19. This table shows the actual death rate due to COVID-19 in the United States between January 2021 and April 2022 compared to the death rate if 100 percent of the population had been vaccinated.

Between the beginning of January 2020 and June 14, 2023, of 1,134,660 deaths caused by COVID-19 in the United States, around 742,587 occurred in an inpatient healthcare setting. This statistic shows the number of coronavirus disease 2019 (COVID-19) deaths in the U.S. from January 2020 to June 2023, by place of death.

Between January 1, 2021 and May 31, 2022, there were approximately 30.6 thousand deaths involving COVID-19 among 80 to 89 year olds in England, with over 14 thousand deaths occurring among unvaccinated people in this age group. Across all the age groups in the provided time interval, deaths involving COVID-19 among the unvaccinated population was around double the amount of people who received at least two doses of a vaccine. For further information about the COVID-19 pandemic, please visit our dedicated Facts and Figures page.

Content

This dataset is all about the coronavirus cases of all countries till 21 January 2021 . This dataset contains 221 rows and 11 columns.The features are: - Country : Name of country - Total Cases : Total cases in each country till 21 January 2021 - New Cases : New Cases on 21 January 2021 - Total Deaths : Total deaths in each country till 21 January 2021 - New Deaths : New deaths on 21 January 2021 - Total Recovered : Total recovery in each country till 21 January 2021 - Active : Active cases in each country till 21 January 2021 - Serious : Serious or critical cases till 21 January 2021 - Tot Cases/1M pop : total cases per 1 million population till 21 January 2021 - Deaths/1M pop : total deaths per 1 million population till 21 January 2021 - Total Tests : Total Tests till 21 January 2021

Acknowledgements

The dataset is scraped from https://www.worldometers.info/coronavirus website

Inspiration

The task is to clean the dataset and doing analysis for the future corona cases

This dataset represents preliminary estimates of cumulative U.S. COVID-19 disease burden for the 2024-2025 period, including illnesses, outpatient visits, hospitalizations, and deaths. The weekly COVID-19-associated burden estimates are preliminary and based on continuously collected surveillance data from patients hospitalized with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. The data come from the Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET), a surveillance platform that captures data from hospitals that serve about 10% of the U.S. population. Each week CDC estimates a range (i.e., lower estimate and an upper estimate) of COVID-19 -associated burden that have occurred since October 1, 2024.

Note: Data are preliminary and subject to change as more data become available. Rates for recent COVID-19-associated hospital admissions are subject to reporting delays; as new data are received each week, previous rates are updated accordingly.

References

1. Reed C, Chaves SS, Daily Kirley P, et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One. 2015;10(3):e0118369. https://doi.org/10.1371/journal.pone.0118369 
2. Rolfes, MA, Foppa, IM, Garg, S, et al. Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness. Influenza Other Respi Viruses. 2018; 12: 132– 137. https://doi.org/10.1111/irv.12486
3. Tokars JI, Rolfes MA, Foppa IM, Reed C. An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States. Vaccine. 2018;36(48):7331-7337. doi:10.1016/j.vaccine.2018.10.026 
4. Collier SA, Deng L, Adam EA, Benedict KM, Beshearse EM, Blackstock AJ, Bruce BB, Derado G, Edens C, Fullerton KE, Gargano JW, Geissler AL, Hall AJ, Havelaar AH, Hill VR, Hoekstra RM, Reddy SC, Scallan E, Stokes EK, Yoder JS, Beach MJ. Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States. Emerg Infect Dis. 2021 Jan;27(1):140-149. doi: 10.3201/eid2701.190676. PMID: 33350905; PMCID: PMC7774540.
5. Reed C, Kim IK, Singleton JA,  et al. Estimated influenza illnesses and hospitalizations averted by vaccination–United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep. 2014 Dec 12;63(49):1151-4. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6349a2.htm 
6. Reed C, Angulo FJ, Swerdlow DL, et al. Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April–July 2009. Emerg Infect Dis. 2009;15(12):2004-2007. https://dx.doi.org/10.3201/eid1512.091413  
7. Devine O, Pham H, Gunnels B, et al. Extrapolating Sentinel Surveillance Information to Estimate National COVID-19 Hospital Admission Rates: A Bayesian Modeling Approach. Influenza and Other Respiratory Viruses. https://onlinelibrary.wiley.com/doi/10.1111/irv.70026. Volume18, Issue10. October 2024.
8. https://www.cdc.gov/covid/php/covid-net/index.html">COVID-NET | COVID-19 | CDC 
9. https://www.cdc.gov/covid/hcp/clinical-care/systematic-review-process.html 
10. https://academic.oup.com/pnasnexus/article/1/3/pgac079/6604394?login=false">Excess natural-cause deaths in California by cause and setting: March 2020 through February 2021 | PNAS Nexus | Oxford Academic (oup.com)
11. Kruschke, J. K. 2011. Doing Bayesian data analysis: a tutorial with R and BUGS. Elsevier, Amsterdam, Section 3.3.5.

The New York Times is releasing a series of data files with cumulative counts of coronavirus cases in the United States, at the state and county level, over time. We are compiling this time series data from state and local governments and health departments in an attempt to provide a complete record of the ongoing outbreak.

Since the first reported coronavirus case in Washington State on Jan. 21, 2020, The Times has tracked cases of coronavirus in real time as they were identified after testing. Because of the widespread shortage of testing, however, the data is necessarily limited in the picture it presents of the outbreak.

We have used this data to power our maps and reporting tracking the outbreak, and it is now being made available to the public in response to requests from researchers, scientists and government officials who would like access to the data to better understand the outbreak.

The data begins with the first reported coronavirus case in Washington State on Jan. 21, 2020. We will publish regular updates to the data in this repository.

These datasets explore disparities in COVID-19 mortality observed in the US and Canada between January 2020 and early March 2021. Table 1 provides counts of deaths, hospitalizations, ICU admissions, and cases, by age, for Ontario, Canada (Canada's most populous province).

Table 2 estimates deaths averted by Canada's response to the COVID-19 pandemic, relative to that in the United States, by "Canada-standardizing" the US epidemic (i.e., by applying US age-specific mortality to Canadian populations, in order to estimate the deaths that would have occurred in a Canadian pandemic with the same rates of death as have been observed in the US). Observed Canadian deaths are compared to "expected" deaths with a US-like response in order to estimate both deaths averted and SMR (Table 2).

As Canadian age groups for purposes of death reporting are slightly different from those used in the US (e.g., 0-17 in the US vs. 0-19 in Canada), we reallocate Canadian deaths based on proportions of deaths occurring in 2-year age categories in Ontario (Table 1).

Ontario age-specific case-fatality is used to inflate the deaths averted, in order to estimate cases averted. Ontario age-specific hospitalization and ICU risk (again derived from Table 1) are used to estimate hospitalizations and ICU admissions averted (Table 2).

As of August 9, 2022, a new dataset has been added which applies the methodology described above to compare deaths in Canada to those in the United Kingdom, France, and Australia. Estimates of QALY loss, and healthcare costs averted, have also been added. Uncertainty bounds are estimated either as parametric confidence intervals, or as upper and lower bound 95% credible intervals through simulation (implemented using the random draw funding in Microsoft Excel).

Errors in confidence intervals for QALY losses in France and Australia corrected February 28, 2023.

Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

The difficulties of death figures

This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

Context

There are two datasets. 1. owid-covid-data.csv :- Contains covid data from 1st Jan 2020 to 7th Feb, 2023 2. owid-covid-latest.csv:- Contains covid data from 8th Feb, 2023.

Content

Dataset Attribute Details:

iso_code: ISO 3166-1 alpha-3 – three-letter country codes continent: Continent of the geographical location location: Geographical location date: Date of observation total_cases: Total confirmed cases of COVID-19 new_cases: New confirmed cases of COVID-19 new_cases_smoothed: New confirmed cases of COVID-19 (7-day smoothed) total_cases_per_million: Total confirmed cases of COVID-19 per 1,000,000 people new_cases_per_million: New confirmed cases of COVID-19 per 1,000,000 people new_cases_smoothed_per_million: New confirmed cases of COVID-19 (7-day smoothed) per 1,000,000 people total_deaths: Total deaths attributed to COVID-19 new_deaths: New deaths attributed to COVID-19 new_deaths_smoothed: New deaths attributed to COVID-19 (7-day smoothed) total_deaths_per_million: Total deaths attributed to COVID-19 per 1,000,000 people new_deaths_per_million: New deaths attributed to COVID-19 per 1,000,000 people new_deaths_smoothed_per_million: New deaths attributed to COVID-19 (7-day smoothed) per 1,000,000 people excess_mortality: Percentage difference between the reported number of weekly or monthly deaths in 2020–2021 and the projected number of deaths for the same period based on previous years. excess_mortality_cumulative: Percentage difference between the cumulative number of deaths since 1 January 2020 and the cumulative projected deaths for the same period based on previous years. excess_mortality_cumulative_absolute: Cumulative difference between the reported number of deaths since 1 January 2020 and the projected number of deaths for the same period based on previous years. excess_mortality_cumulative_per_million: Cumulative difference between the reported number of deaths since 1 January 2020 and the projected number of deaths for the same period based on previous years, per million people. icu_patients: Number of COVID-19 patients in intensive care units (ICUs) on a given day icu_patients_per_million: Number of COVID-19 patients in intensive care units (ICUs) on a given day per 1,000,000 people hosp_patients: Number of COVID-19 patients in the hospital on a given day hosp_patients_per_million: Number of COVID-19 patients in hospital on a given day per 1,000,000 people weekly_icu_admissions: Number of COVID-19 patients newly admitted to intensive care units (ICUs) in a given week weekly_icu_admissions_per_million: Number of COVID-19 patients newly admitted to intensive care units (ICUs) in a given week per 1,000,000 people weekly_hosp_admissions: Number of COVID-19 patients newly admitted to hospitals in a given week weekly_hosp_admissions_per_million: Number of COVID-19 patients newly admitted to hospitals in a given week per 1,000,000 people stringency_index: Government Response Stringency Index: composite measure based on 9 response indicators including school closures, workplace closures, and travel bans, rescaled to a value from 0 to 100 (100 = strictest response) reproduction_rate: Real-time estimate of the effective reproduction rate (R) of COVID-19. total_tests: Total tests for COVID-19 new_tests: New tests for COVID-19 (only calculated for consecutive days) total_tests_per_thousand: Total tests for COVID-19 per 1,000 people new_tests_per_thousand: New tests for COVID-19 per 1,000 people new_tests_smoothed: New tests for COVID-19 (7-day smoothed). For countries that don't report testing data on a daily basis, we assume that testing changed equally on a daily basis over any periods in which no data was reported. This produces a complete series of daily figures, which is then averaged over a rolling 7-day window new_tests_smoothed_per_thousand: New tests for COVID-19 (7-day smoothed) per 1,000 people positive_rate: The share of COVID-19 tests that are positive, given as a rolling 7-day average (this is the inverse of tests_per_case) tests_per_case: Tests conducted per new confirmed case of COVID-19, given as a rolling 7-day average (this is the inverse of positive_rate) tests_units: Units used by the location to report its testing data total_vaccinations: Total number of COVID-19 vaccination doses administered people_vaccinated: Total number of people who received at least one vaccine dose people_fully_vaccinated: Total number of people who received all doses prescribed by the vaccination protocol total_boosters: Total number of COVID-19 vaccination booster doses administered (doses administered beyond the number prescribed by the vaccination protocol) new_vaccinations: New COVID-19 vaccination doses a...

Age-standardised mortality rates for deaths involving coronavirus (COVID-19), non-COVID-19 deaths and all deaths by vaccination status, broken down by age group.

Between the beginning of January 2020 and June 14, 2023, of the 1,134,641 deaths caused by COVID-19 in the United States, around 307,169 had occurred among those aged 85 years and older. This statistic shows the number of coronavirus disease 2019 (COVID-19) deaths in the U.S. from January 2020 to June 2023, by age.

The United States is the country with the greatest number of COVID-19 deaths in 2020, 2021, and 2022. Both the U.S. and the world exhibited an increase in the number of COVID-related deaths in 2021 and a decrease in 2022. The U.S. share of COVID-related deaths declined in 2021 but rose in 2022, leading to a cumulative total U.S. mortality share of 17%. The extent to which the U.S. is an outlier is even greater based on the monetized mortality costs. Using the value of a statistical life to monetize the mortality impact increases the performance gap between the U.S. and the rest of the world because of the high mortality risk valuation in the U.S. The worldwide COVID-19 mortality cost was $29.4 trillion as of January 1, 2023, with a U.S. share of $12.7 trillion, or 43% of the global total. Throughout the COVID pandemic, the U.S. mortality cost share has been in the narrow range of 43% to 45%. Given the high U.S. value of a statistical life, these monetized mortality cost values are more than double the U.S. share of COVID-related deaths. The U.S. mortality cost share is greater if the value of a statistical life declines more than proportionally with income for low-income countries.

As of April 26, 2023, the number of both confirmed and presumptive positive cases of the COVID-19 disease reported in the United States had reached over 104 million with over 1.1 million deaths reported among these cases.

Coronavirus deaths by age in the U.S. Daily new cases of COVID-19 hit record highs in the United States at the beginning of 2022. Underlying health conditions can worsen cases of coronavirus, and case fatality rates among confirmed COVID-19 patients increase with age. The highest number of deaths from COVID-19 have been among those aged 85 years and older, with this age group accounting for over 300 thousand deaths.

Where has this coronavirus come from? Coronaviruses are a large group of viruses transmitted between animals and people that cause illnesses ranging from the common cold to more severe diseases. The novel coronavirus that is currently infecting humans was already circulating among certain animal species. The first human case of this new coronavirus strain was reported in China at the end of December 2019. The coronavirus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and its associated disease is known as COVID-19.

The Public Health Research Database (PHRD) is a linked asset which currently includes Census 2011 data; Mortality Data; Hospital Episode Statistics (HES); GP Extraction Service (GPES) Data for Pandemic Planning and Research data. Researchers may apply for these datasets individually or any combination of the current 4 datasets.

The purpose of this dataset is to enable analysis of deaths involving COVID-19 by multiple factors such as ethnicity, religion, disability and known comorbidities as well as age, sex, socioeconomic and marital status at subnational levels. 2011 Census data for usual residents of England and Wales, who were not known to have died by 1 January 2020, linked to death registrations for deaths registered between 1 January 2020 and 8 March 2021 on NHS number. The data exclude individuals who entered the UK in the year before the Census took place (due to their high propensity to have left the UK prior to the study period), and those over 100 years of age at the time of the Census, even if their death was not linked. The dataset contains all individuals who died (any cause) during the study period, and a 5% simple random sample of those still alive at the end of the study period. For usual residents of England, the dataset also contains comorbidity flags derived from linked Hospital Episode Statistics data from April 2017 to December 2019 and GP Extraction Service Data from 2015-2019.

Logistic regression models examining differences between Arab American patients and other racial and ethnic groups on odds of testing positive for COVID-19, being admitted due to COVID-19, and in-hospital mortality for patients at Sharp Grossmont hospital between March 1, 2020 and January 31, 2021.

New Covid deaths per million people in Swaziland, March, 2023 The most recent value is 2 new Covid deaths per million people as of March 2023, an increase compared to the previous value of 1 new Covid deaths per million people. Historically, the average for Swaziland from February 2020 to March 2023 is 31 new Covid deaths per million people. The minimum of 0 new Covid deaths per million people was recorded in February 2020, while the maximum of 314 new Covid deaths per million people was reached in January 2021. | TheGlobalEconomy.com